OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
ACE-III (Cognitive Examination)AIMS (Tardive Dyskinesia)ASRM (Altman Mania Scale)ASRS-v1.1 (Adult ADHD Screen)ASSIST (WHO Substance Screen)AUDIT (Alcohol Use Disorders)AUDIT-C (Alcohol Screen)BARS (Akathisia)BDI-II (Beck Depression)BPRS (Brief Psychiatric Rating)BSDS (Bipolar Spectrum Screen)C-SSRS (Suicide Severity)CAGE QuestionnaireCAPS-5 (PTSD Clinical Interview)CDR (Dementia Staging)CDSS (Schizophrenia Depression)CIWA-Ar (Alcohol Withdrawal)COWS (Opioid Withdrawal)Clozapine Safety (REMS)DAST-10 (Drug Abuse Screen)DES-II (Dissociation Scale)EDE-Q (Eating Disorder Severity)EPDS (Postnatal Depression)Epworth Sleepiness ScaleFAST (Alzheimer's Staging)Fagerstrom (Nicotine Dependence)GAD-2 (Anxiety Screen)GAD-7 (Anxiety Severity)GAF (Global Functioning)HAM-D 17 (Hamilton Depression)HCL-32 (Hypomania Checklist)IES-R (Trauma Impact)ISI (Insomnia Severity)LSAS (Social Anxiety)MADRS (Depression Rating)MARSIPAN (Medical Risk in AN)MDQ (Bipolar Screen)MSI-BPD (Borderline PD Screen)Manchester Self-Harm RuleMetabolic Syndrome (Psych)MoCA (Cognitive Assessment)OCI-R (OCD Screen)PANSS (Schizophrenia Severity)PCL-5 (PTSD Checklist DSM-5)PHQ Panic ModulePHQ-2 (Depression Screen)PHQ-9 (Depression Severity)PSP (Personal/Social Performance)PSQI (Pittsburgh Sleep Quality)QTc Prolongation (Psychiatry)SAD PERSONS ScaleSAFE-T ProtocolSBQ-R (Suicidal Behaviors)SCOFF (Eating Disorder Screen)SPIN (Social Phobia)Simpson-Angus Scale (EPS)Y-BOCS (OCD Severity)YMRS (Mania Severity)
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

BDI-II (Beck Depression)

Beck Depression Inventory (BDI-II)

Validated self-report inventory for measuring depression severity. Base answers on how you have felt over the past two weeks.

1

Sadness

2

Pessimism

3

Past Failure

4

Loss of Pleasure

5

Guilty Feelings

6

Punishment Feelings

7

Self-Dislike

8

Self-Criticalness

9

Suicidal Thoughts or Wishes

10

Crying

11

Agitation

12

Loss of Interest

13

Indecisiveness

14

Worthlessness

15

Loss of Energy

16

Changes in Sleeping Pattern

17

Irritability

18

Changes in Appetite

19

Concentration Difficulty

20

Tiredness or Fatigue

21

Loss of Interest in Sex

© OpiCalc Clinical Intelligence

Beck AT, et al. (1996)

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Clinical Utility

Self-reported assessment of the severity of depressive symptoms in adults and adolescents (aged 13+).
Screening tool in primary care or psychiatric settings.
Monitoring symptom changes over the course of treatment (pharmacotherapy or CBT).
Differentiating between cognitive-affective and somatic-vegetative symptoms of depression.

User Guide

The BDI-II is a self-rating scale. Patients should base their selections on how they have been feeling over the past two weeks, including today (consistent with DSM criteria).
Section 2

Formula & Logic

Scoring Interpretation

Score 0 – 13Minimal Depression
Score 14 – 19Mild Depression
Score 20 – 28Moderate Depression
Score 29 – 63Severe Depression

The 21-Item Framework

The scale consists of 21 groups of statements. Each item is scored on a scale value of 0 to 3. The total score range is 0 to 63.
Section 3

Pearls/Pitfalls

The Suicide Red Flag

Item 9 (Suicidal Thoughts) is a critical safety marker. Regardless of the total score, any non-zero response on item 9 requires immediate clinical follow-up and risk assessment.

Diagnostic Pearls

The BDI-II is highly sensitive to treatment-induced change, making it ideal for tracking CBT progress.
Consider "Atypical Depression" if somatic items (sleep, appetite) are high while cognitive items remain moderate.
Be aware of "Social Desirability Bias"—some patients may under-report symptoms to appear "better" to the provider.
Section 4

Next Steps

Treatment Thresholds

01
Score < 14: Maintain current support; repeat screen in 3–6 months if clinically indicated.
02
Score 14 – 19: Consider psychotherapy (CBT/IPT) or cautious initiation of SSRI if symptoms persist.
03
Score > 20: Standard threshold for recommending combined treatment (pharmacotherapy + psychotherapy).
04
Global Follow-up: Always correlate the BDI-II score with a clinical interview to confirm the diagnosis of MDD.
Section 5

Evidence Appraisal

Primary Reference

Manual for the Beck Depression Inventory-II

Beck AT et al. • Psychological Corporation. 1996;San Antonio, TX. The definitive manual updating the 1961 version to align with DSM-IV criteria.

Section 6

Literature

Dr. Aaron T. Beck

Developed by Aaron T. Beck, the father of Cognitive Behavioral Therapy (CBT). The BDI-II was specifically designed to capture the negative cognitive distortions that Beck identified as central to the pathology of depression.

Last Comprehensive Review: 2026

Related Psychiatry Tools

PHQ-9
PHQ-2
MADRS
EPDS
Geriatric Depression Scale
Quick Inventory of Depressive Symptomatology
Inventory of Depressive Symptomatology
Patient Health Questionnaire for Adolescents
Alzheimer's Disease Assessment Scale — Cognitive
Eating Attitudes Test
Have feedback about this calculator?Let us know.